AMTX Share Price | Aemetis, Inc. Stock Analysis & Recommendation

Q: Is Aemetis, Inc. technically bullish or bearish?

As of 10 September 2025, the technical trend for Aemetis, Inc. has changed from sideways to mildly bearish. The weekly MACD and KST indicators are both mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals across time frames. The daily moving averages are mildly bullish, but the overall sentiment is dampened by the weekly and monthly Dow Theory and OBV being mildly bearish. In terms of performance, Aemetis has underperformed the S&P 500 across multiple periods, with a year-to-date return of -10.04% compared to the S&P 500's 12.22%, and a three-year return of -68.85% versus the S&P 500's 70.41%. Overall, the current technical stance is mildly bearish.

Q: How big is Aemetis, Inc.?

Market Cap: As of Jun 18, Aemetis, Inc. has a market capitalization of 125.13 million, classifying it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, Aemetis, Inc. reported net sales of 237.89 million and a net profit of -87.83 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of -263.93 million and total assets of 259.30 million.

Q: What does Aemetis, Inc. do?

Overview: Aemetis, Inc. is an international renewable fuels and biochemicals company operating in the specialty chemicals industry with a micro-cap market capitalization.Financial Snapshot: Net Sales: 43 Million (Quarterly Results - Mar 2025) Net Profit: -25 Million (Quarterly Results - Mar 2025) Market cap: USD 125.13 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.65 Return on Equity: 31.29% Price to Book: -0.45Contact Details: Address: 20400 Stevens Creek Blvd Ste 700, CUPERTINO CA : 95014-2296 Tel: 1 408 5173304 Fax: 1 408 2528044 Website: http://www.aemetis.com/

Q: Should I buy, sell or hold Aemetis, Inc.?

Based on the current financial situation of Aemetis, Inc., it is advisable to consider a strong sell position. The company is facing significant challenges, including a negative book value and weak long-term fundamental strength. The operating profit has declined dramatically at an annual rate of -250.46% over the past five years, indicating poor long-term growth prospects.Additionally, the company's ability to service its debt is concerning, with an EBIT to interest ratio of -0.60, suggesting that it struggles to cover its interest expenses. Recent financial results show a net profit loss of USD -58.66 million, which has worsened by -209.36%. The raw material costs have surged by 598.37% year-over-year, further straining the company's finances.The debt-equity ratio is alarmingly high at -166.64%, indicating excessive debt relative to equity. Furthermore, the stock has generated no returns over the past year while profits have plummeted by -98.6%. Given these factors, holding or buying Aemetis, Inc. carries significant risk, and selling may be the most prudent course of action.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

257.98 k

Shareholding (Jun 2026)

FII

2.68%

Held by 33 FIIs

DII

97.32%

Held by 14 DIIs

Promoter

0.00%

Is Aemetis, Inc. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, Aemetis, Inc. shows a mildly bearish trend with mixed signals from various indicators and has significantly underperformed the S&P 500, with a year-to-date return of -10.04% compared to the S&P's 12.22%.

View full answer

How big is Aemetis, Inc.?

22-Jun-2025

As of Jun 18, Aemetis, Inc. has a market capitalization of 125.13 million, with net sales of 237.89 million and a net profit of -87.83 million over the last four quarters. The company reported shareholder's funds of -263.93 million and total assets of 259.30 million as of Dec 24.

View full answer

What does Aemetis, Inc. do?

22-Jun-2025

Aemetis, Inc. is a renewable fuels and biochemicals company with a market cap of $125.13 million, reporting net sales of $43 million and a net loss of $25 million as of March 2025. The company operates in the specialty chemicals industry and has a negative debt equity ratio of -1.65.

View full answer

Who are in the management team of Aemetis, Inc.?

22-Jun-2025

As of March 2022, the management team of Aemetis, Inc. includes Chairman and CEO Eric McAfee, Director Dr. Naomi Boness, and Independent Directors Francis Barton, Lydia Beebe, and John Block.

View full answer

Should I buy, sell or hold Aemetis, Inc.?

22-Jun-2025

Compare Aemetis, Inc. with Similar Stocks

Origin Materials, Inc.Loop Industries, Inc.Danimer Scientific, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.60

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

USD 220 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.64

Return on Equity

25.10%

Price to Book

-0.72

Revenue and Profits:

Net Sales:

63 Million

(Quarterly Results - Jun 2026)

Net Profit:

-9 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

5.56%

6 Months

-29.63%

1 Year

-20.17%

2 Years

-22.76%

3 Years

-55.19%

4 Years

-70.63%

5 Years

-87.21%

Aemetis, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.67%

EBIT Growth (5y)

-232.81%

EBIT to Interest (avg)

-0.60

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.65

Sales to Capital Employed (avg)

1.22

Tax Ratio

17.39%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

22.27%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.72

EV to EBIT

-19.47

EV to EBITDA

-26.82

EV to Capital Employed

3.66

EV to Sales

3.48

PEG Ratio

Dividend Yield

ROCE (Latest)

-18.82%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 15 Schemes (11.58%)

Foreign Institutions

Held by 33 Foreign Institutions (2.68%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 14.84% vs 1.68% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 56.68% vs -309.43% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62.70",
          "val2": "54.60",
          "chgp": "14.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.40",
          "val2": "-3.70",
          "chgp": "327.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.20",
          "val2": "16.00",
          "chgp": "-5.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.40",
          "val2": "-21.70",
          "chgp": "56.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.10%",
          "val2": "-116.00%",
          "chgp": "20.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -22.27% vs 43.33% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 12.00% vs -88.58% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "208.00",
          "val2": "267.60",
          "chgp": "-22.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-27.00",
          "val2": "-31.50",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "61.10",
          "val2": "59.30",
          "chgp": "3.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-77.00",
          "val2": "-87.50",
          "chgp": "12.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-178.90%",
          "val2": "-151.00%",
          "chgp": "-2.79%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

62.70

54.60

14.84%

Operating Profit (PBDIT) excl Other Income

8.40

-3.70

327.03%

Interest

15.20

16.00

-5.00%

Exceptional Items

0.00

Consolidate Net Profit

-9.40

-21.70

56.68%

Operating Profit Margin (Excl OI)

92.10%

-116.00%

20.81%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 14.84% vs 1.68% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 56.68% vs -309.43% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

208.00

267.60

-22.27%

Operating Profit (PBDIT) excl Other Income

-27.00

-31.50

14.29%

Interest

61.10

59.30

3.04%

Exceptional Items

0.00

Consolidate Net Profit

-77.00

-87.50

12.00%

Operating Profit Margin (Excl OI)

-178.90%

-151.00%

-2.79%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -22.27% vs 43.33% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 12.00% vs -88.58% in Dec 2024

All Annual Results

Company CV

About Aemetis, Inc.

Aemetis, Inc.

Specialty Chemicals

Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company's approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company's over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.

Company Coordinates

Company Details

20400 Stevens Creek Blvd Ste 700 , CUPERTINO CA : 95014-2296

Tel: 1 408 5173304

http://www.aemetis.com/

Registrar Details

Footer loading